Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.35+0.01 (+2.91%)
Close on Nov 18, 2026Market cap $3.05MP/E 0.3Yield –
Evogene net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$8.49M. The highest annual figure on record is -$8.49M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.49M | – |
| FY2024 | Dec 31, 2024 | -$16.49M | – |
| FY2023 | Dec 31, 2023 | -$23.88M | – |
| FY2022 | Dec 31, 2022 | -$26.64M | – |
| FY2021 | Dec 31, 2021 | -$27.79M | – |
| FY2020 | Dec 31, 2020 | -$23.37M | – |
| FY2019 | Dec 31, 2019 | -$18.11M | – |
| FY2018 | Dec 31, 2018 | -$20.76M | – |
| FY2017 | Dec 31, 2017 | -$20.84M | – |
| FY2016 | Dec 31, 2016 | -$19.59M | – |
See a number that looks wrong?